1
|
Sanchez Klose FP, Dahlstrand Rudin A, Bergqvist L, Scheffler JM, Jönsson K, Islander U, Karlsson-Bengtsson A, Bylund J, Venkatakrishnan V. The Pseudomonas aeruginosa lectin LecB modulates intracellular reactive oxygen species production in human neutrophils. Eur J Immunol 2024; 54:e2350623. [PMID: 37972111 DOI: 10.1002/eji.202350623] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2023] [Revised: 11/09/2023] [Accepted: 11/15/2023] [Indexed: 11/19/2023]
Abstract
Pseudomonas aeruginosa is a Gram-negative bacterium and an opportunistic pathogen ubiquitously present throughout nature. LecB, a fucose-, and mannose-binding lectin, is a prominent virulence factor of P. aeruginosa, which can be expressed on the bacterial surface but also be secreted. However, the LecB interaction with human immune cells remains to be characterized. Neutrophils comprise the first line of defense against infections and their production of reactive oxygen species (ROS) and release of extracellular traps (NETs) are critical antimicrobial mechanisms. When profiling the neutrophil glycome we found several glycoconjugates on granule and plasma membranes that could potentially act as LecB receptors. In line with this, we here show that soluble LecB can activate primed neutrophils to produce high levels of intracellular ROS (icROS), an effect that was inhibited by methyl fucoside. On the other hand, soluble LecB inhibits P. aeruginosa-induced icROS production. In support of that, during phagocytosis of wild-type and LecB-deficient P. aeruginosa, bacteria with LecB induced less icROS production as compared with bacteria lacking the lectin. Hence, LecB can either induce or inhibit icROS production in neutrophils depending on the circumstances, demonstrating a novel and potential role for LecB as an immunomodulator of neutrophil functional responses.
Collapse
Affiliation(s)
| | - Agnes Dahlstrand Rudin
- Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Linda Bergqvist
- Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Julia M Scheffler
- Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Katarina Jönsson
- Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Ulrika Islander
- Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- SciLifeLab, University of Gothenburg, Gothenburg, Sweden
| | - Anna Karlsson-Bengtsson
- Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden
- Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Johan Bylund
- Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | | |
Collapse
|
2
|
Susceptibility of airways to Pseudomonas aeruginosa infection: mouse neuraminidase model. MONATSHEFTE FUR CHEMIE 2017. [DOI: 10.1007/s00706-017-2035-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
3
|
Vašková L, Nosková L, Bláhová B, Wimmerová M, Dřevínek P, Kubíčková B, Stiborová M, Hodek P. Evaluation of anti-PAIIL lectin hen yolk antibody as an agent inhibiting Pseudomonas aeruginosa adherence to epithelial cells. MONATSHEFTE FUR CHEMIE 2016. [DOI: 10.1007/s00706-016-1687-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
4
|
Grishin AV, Krivozubov MS, Karyagina AS, Gintsburg AL. Pseudomonas Aeruginosa Lectins As Targets for Novel Antibacterials. Acta Naturae 2015; 7:29-41. [PMID: 26085942 PMCID: PMC4463410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Pseudomonas aeruginosa is one of the most widespread and troublesome opportunistic pathogens that is capable of colonizing various human tissues and organs and is often resistant to many currently used antibiotics. This resistance is caused by different factors, including the acquisition of specific resistance genes, intrinsic capability to diminish antibiotic penetration into the bacterial cell, and the ability to form biofilms. This situation has prompted the development of novel compounds differing in their mechanism of action from traditional antibiotics that suppress the growth of microorganisms or directly kill bacteria. Instead, these new compounds should decrease the pathogens' ability to colonize and damage human tissues by inhibiting the virulence factors and biofilm formation. The lectins LecA and LecB that bind galactose and fucose, as well as oligo- and polysaccharides containing these sugars, are among the most thoroughly-studied targets for such novel antibacterials. In this review, we summarize the results of experiments highlighting the importance of these proteins for P. aeruginosa pathogenicity and provide information on existing lectins inhibitors and their effectiveness in various experimental models. Particular attention is paid to the effects of lectins inhibition in animal models of infection and in clinical practice. We argue that lectins inhibition is a perspective approach to combating P. aeruginosa. However, despite the existence of highly effective in vitro inhibitors, further experiments are required in order to advance these inhibitors into pre-clinical studies.
Collapse
Affiliation(s)
- A. V. Grishin
- Gamaleya Research Center of Epidemiology and Microbiology, Gamaleya Str., 18, Moscow, 123098, Russia,Institute of Agricultural Biotechnology, Timiryazevskaya Str., 42, Moscow, 127550, Russia
| | - M. S. Krivozubov
- Gamaleya Research Center of Epidemiology and Microbiology, Gamaleya Str., 18, Moscow, 123098, Russia
| | - A. S. Karyagina
- Gamaleya Research Center of Epidemiology and Microbiology, Gamaleya Str., 18, Moscow, 123098, Russia,Institute of Agricultural Biotechnology, Timiryazevskaya Str., 42, Moscow, 127550, Russia,Belozersky Institute of Physical and Chemical Biology, Lomonosov Moscow State University, Leninskie Gory, 1, bld. 40, Moscow, 119991, Russia
| | - A. L. Gintsburg
- Gamaleya Research Center of Epidemiology and Microbiology, Gamaleya Str., 18, Moscow, 123098, Russia
| |
Collapse
|